Pathology Technology Australia

As we wrap up another massive year, click on the images below to see what our small but mighty team has achieved in 2024. Can you help us with our final goal of hitting 3k followers? Dean Whiting, Chami Lam. Madeline O'Donoghue, and Justin Meredith wish all our members, stakeholders, friends, and collaborators a restful holiday break. We look forward to working with all of you as we continue to find better ways of getting the right test in front of the right patient at the right time. #Diagnostics #2024WrapUp #PathologyTechnology #genomics #PointOfCare #HealthEconomics #MedTech

Today we bid farewell (but not goodbye) to our friend and colleague Justin Meredith. Justin has been our Stakeholder Engagement Lead for the past 3 years. In that time, we have seen incredible growth in our organisation. Many thanks Justin and best wishes for your very bright future, in whatever you choose to do. Chami Lam, Madeline O'Donoghue, Dean Whiting and the members of Pathology Technology Australia

Novak Laforest and Jeremy Tyson have been elected as Co-deputy Chairs on the Board at Pathology Technology Australia. Fabian Ehlen has been re-elected as Treasurer. PTA CEO, Dean Whiting, welcomed the appointments, noting that Novak and Jeremy bring a huge depth of industry experience to the position in support of our Chair, Allison Rossiter GAICD. Fabian has deep industry financial experience and has contributed strongly as our Treasurer over the past couple of years. "Our Board is now approaching full strength" said Dean, "and I am thrilled to have such a strong team in place."

Warmest welcome to the latest addition for our Board of Directors - Tony Bhalla GAICD, Oceania Sales and Service Leader at Revvity. Tony's passion for driving innovative solutions that advance access and equity in healthcare sits squarely within our core strategic goals. With 17+ years of commercial and strategic leadership and a Company Directors Course under his belt, we are thrilled to have him on-board! Under the guidance of our newly appointed chair Allison Rossiter GAICD and alongside our seasoned and refreshed Board members 2025 is shaping up to be another enormous year. Have you hit the 'follow us' button to make sure you don't miss any important developments? #Diagnostics #FutureHealth #PathologyTechnology #HealthInnovation #Genomics #PointOfCareTesting #DigitalHealth #WeArePTA Dean Whiting Simon Giuliano Novak Laforest Fabian Ehlen Jenny Carson Madeline O'Donoghue Justin Meredith Cyrus Boomla Jeremy Tyson

Changing of the guard at PTA. Domenic Stranieri has now completed his term as Chair of the Board at PTA. CEO Dean Whiting expressed thanks to Domenic for his thoughtful stewardship. And PTA welcomes Allison Rossiter GAICD as the new Chair.  With a background in Computing & Informatics, teamed with over 22 years of healthcare experience in four countries, Ali brings substantial experience, and we welcome her leadership and experience. Novak Laforest Simon Giuliano Jeremy Tyson Cyrus Boomla Fabian Ehlen, Jenny Carson #wearepta

And now for something completely different! Our CEO Dean Whiting convened a fun way to review the year that was. PTA’s #DrinksWithDean kicked off with our CEO demonstrating how he makes his favourite cocktail, the classic Negroni. And as he consumed said cocktail, the discussion became progressively more fun. Not surprising given the gorilla with the pink flamingo floaty shirt Dean was wearing. Never-the-less, an outstanding year for PTA and our members was duly reviewed and season’s greetings exchanged. The only thing left to say is, follow PTA on LinkedIn and you too could participate in one of our events. Madeline O'Donoghue Justin Meredith Chami Lam #wearepta

PTA-Academy’s training course on Fiduciary and Legal Responsibilities for Senior Management has achieved a Net Promotor Score (NPS) of 100! And quotes from participants such as this: “I was fortunate enough to attend PTA’s director training course last week. What a brilliant opportunity to learn about director responsibilities and broad accountability. Thank you to the PTA team for organising this.” Follow PTA on LinkedIn and check https://lnkd.in/gs6nPfVh to learn more about our courses. 

Staying informed on fiduciary and legal responsibilities is an essential task for managers. The latest group of participants in PTA-Academy's training course on Legal and Fiduciary Responsibilities for Senior Managers is now fully up to speed. Congratulations to Allison Rossiter GAICD, Jeremy Tyson, Novak Laforest, Simon Giuliano, Peter Symeou, Kate Driver, Deanne Anson, Nam Nguyen for completing the course. And many thanks to our expert trainer Anthony Loschiavo. To learn about more PTA-Academy courses go to Pathologytechnology.org.au and follow us on LinkedIn. Dean Whiting #wearepta

Experiencing migraines and impaired coordination, Kathy was not expecting to come back from hospital with a lung cancer diagnosis.   Like over 40% of newly diagnosed lung cancer patients, her cancer was already Stage 4 and terminal.   The good news? Genomic testing of Kathy’s cancer identified a specific gene for which there is a targeted treatment. Kathy can take a daily pill that is currently keeping her alive.   Genomic testing has spurred an acceleration in understanding of the mutations underlying cancer. We are in an explosive era of targeted therapy development informed by pathology technology.   “If every single lung cancer patient in Australia had access to this technology, their treatments will be improved, their outcomes will be improved, their quality of life will be improved” Christa Bayer – Lung Cancer Foundation.   Lung cancer is still the deadliest of all cancers in Australia, accounting for almost 9,000 deaths in 2023. However, thanks to more widespread use of personalised treatments informed by genetic testing, 5-year survival rates have more than doubled over the past 30 yrs—now at 24%.   Receiving Government funded genetic testing for lung-cancer gene mutations was an almost decade-long process. As our understanding evolves, patients cannot afford more lengthy delays to access updated tests and therapies.   We need system-wide evolution in how we fund and provide genetic testing, so patients like Kathy have the best chance of survival.   Hear Kathy’s story and the impassioned plea from Lung Cancer Foundation’s Christa Bayer for more timely access to diagnosis and genetic profiling. https://lnkd.in/g4rwZSCc   Follow us at Pathology Technology Australia and learn how we are championing for genomic-led cancer care. Visit The Missing Piece website for more on the importance of pathology technology—providing the right test, for the right patient, at the right time: https://lnkd.in/gZmUdSVz. Dean Whiting Madeline O'Donoghue #lungcancer #pathology Lung Foundation Australia

We draw attention to the shocking discrepancies between men and women and the challenges in men's health this International Men's Day: - Australian men are twice as likely as women to die before 75 years from preventable causes. -  Australian men are more than 3 times as likely as women to die from suicide. - Less than 1 in 30 Australian men eat enough fruit and vegetables. - Only 1 in 4 men are *not* overweight or obese. The theme of #InternationalMensDay2024 is "Positive Male Role Models". We believe we need more positive role models in men's preventative health. So we challenge you to play our International Men's Bingo game: - Look through the bingo card in the image below - Count your score and record it in the comment section - Tag a friend who you think needs a boost - Follow us for all the latest information on how pathology technology supports preventative health measures #MensHealth #InternationalMensDay #PreventativeHealth #Diagnostics #PathologyTechnology #WeArePTA Dean Whiting Justin Meredith Jeremy Tyson Colin Denver Simon Giuliano Vito Trifilo Domenic Stranieri